VP of Clinical Research DCN Dx Carlsbad, California, United States
In this session, Emily Friedland of DCN Dx outlines a proven framework for aligning clinical and regulatory programs across the IVD lifecycle. Drawing on her experience as head of regulatory and clinical strategy at a leading IVD CRO/CDMO (DCN Dx), she highlights common causes of rework, delays, and costly amendments, and how cross-functional planning can prevent them. Learn how to optimize protocol design, usability, biostatistics, and global submission strategy for faster, more predictable outcomes.
